Article
Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study.
Cancer medicine - 1 Mar 2023
Rapado-González Óscar, Brea-Iglesias Jenifer, Rodríguez-Casanova Aitor, Bao-Caamano Aida, López-Cedrún José-Luis, Triana-Martínez Gabriel, Díaz-Peña Roberto, Santos María Arminda, López-López Rafael, Muinelo-Romay Laura, Martínez-Fernández Mónica, Díaz-Lagares Ángel, Suárez-Cunqueiro María Mercedes
Abstract excerpt
BACKGROUND: We explore the utility of TruSight Tumor 170 panel (TST170) for detecting somatic mutations in tumor and cfDNA from locoregional recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). METHODS: Targeted NGS of tumor DNA and plasma cfDNA was performed using TST170 panel. In addition, a set of somatic mutations previously described in HNSCC were selected for validating in tumor,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
